Clinical Trials
TB Vaccine Which Is Temperature Stable Gives Immune Response
ID93+GLA-SE, a freeze-dried tuberculosis vaccine, was confirmed to be safe in the first clinical study of any subunit TB vaccine in a temperature-stable form.
The effectiveness of a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two...
Drug Research
Guidance On mAbs, Therapeutic Proteins Potency Issued By FDA
The FDA has gone on to issue guidance on March 2, 2023 in order to give out recommendations to sponsors that will help in monoclonal antibodies- mAbs creation as well as other therapeutic proteins which go on to target...
News
Statutory Scheme Increase By The UK Gets A Pharma Response
The UK government has gone on to confirm its plans to move ahead with the proposed statutory scheme pharma rate surge. This means that the revenue recovery rate paid by the pharma companies that are subject to the statutory...
Drug Research
Protein Drug Manufacturing May Get New Purification Method
In a recent study, researchers at the Massachusetts Institute of Technology (MIT) have come up with a new purification approach to reduce the cost of making protein drugs. So as to isolate proteins from a bioreactor rapidly and cheaply,...
News
5 Surprising Benefits of Adding Protein Powder to Your Diet
Are you looking for an easy way to improve your nutrition, support muscle growth and kickstart your metabolism? Then, adding protein powder to your diet might be the answer. Protein powder is a fast-acting, nutrient-dense dietary supplement packed with...
Drug Research
NIIMBL Unveils 3 New Vaccine Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute's Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro...
Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















